Consistently, we found that cGAS enhances the disease severity of PD, by aggregating PD‐related behavior, and decreasing the loss of TH‐positive neurons and the number of activated microglial cells in cGas−/− mice during PD. This evidence concerns the gene CGAS and Parkinson disease.